Improving adherence in ulcerative colitis (UC) patients on 5-ASA.

Improving adherence in ulcerative colitis (UC) patients on 5-ASA. - Improving adherence in UC patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON40052

Enrollment

220

Registered

2014-03-06

Start date

2014-09-03

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease ulcerative colitis

Interventions

Randomisation: Once versus twice daily 5-ASA therapy to improve their compliance to 5ASA//Text messages and alerts via a specific app on their mobile phone versus standard of care to improve their c

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age>18 and

Exclusion criteria

Exclusion criteria: Pregnancy Concomitant use of immunosuppressives Use of immunosuppressives in the prior 3 months No access to mobile phone

Design outcomes

Primary

Measure	Time frame
Adherence measured as 5-ASA-metabolites in urine	—

Secondary

Measure	Time frame
1. quality of life 2. clinical as well as endoscopic remission 3. costs 4. safety 5. adherence as measured with questionnaires in UC patients on 5-ASA	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)